Atlas Trials

Safety and Efficacy of Low-dose hEparinization in Cerebral Angiography sTudy

Clinical trial NCT06365398 · COMPLETED

Trial details

NCT number
NCT06365398
Sponsor
Xuanwu Hospital, Beijing
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cerebral AngiographyHeparinization
Start date
2018-01-01
Primary completion
2021-06-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.